Ilir Mujalovic is a leading capital markets lawyer whose practice focuses on complex equity capital markets and corporate finance transactions.

He represents issuers and investment banks on a wide variety of matters, including initial public offerings, follow-on offerings, PIPEs, ATMs, SPACs, de-SPACs, convertible bonds, investment grade notes, high-yield debt offerings, and other public and private transactions.

Ilir works with clients across many industries, including healthcare, consumer/retail, media and telecommunications, industrials, power and utilities, renewables, and financial institutions, among others.

He has developed a stellar reputation representing clients on numerous biotech, med-tech, diagnostics, and healthcare services transactions. He also represents corporate clients such as Valvoline Inc. in connection with corporate governance and SEC compliance matters and works with leading investment banks including BofA Securities, Morgan Stanley, Citi, Goldman Sachs, J.P. Morgan, TD Cowen, Barclays, Deutsche Bank, Jefferies, Piper Sandler, Santander, Leerink, and UBS.

Ilir joined the firm as a partner in 2026 from another major international law firm. From August 2010 through February 2014, he was a Director and Assistant General Counsel at Bank of America Merrill Lynch where he advised on a broad range of equity and high-yield capital markets transactions.

Read More

Notable Experience (including those prior to joining Cleary)

Equity Offerings

  • BofA Securities, Piper Sandler, J.P. Morgan and Goldman Sachs & Co. LLC as representatives of the underwriters in connection with the upsized follow-on offering by Kestra Medical Technologies Ltd. of 6.9 million shares of common stock at a public offering price of $23 per share, resulting in gross proceeds of approximately $158.7 million.

  • TD Securities and Goldman Sachs as underwriters in connection with a $13.1 billion secondary registered offering of shares of The Charles Schwab Corporation by The Toronto-Dominion Bank. The transaction marked the largest financial services public equity offering of the past five years and one of the largest equity offerings in the United States in a decade. Through the equity offering and a $1.5 billion repurchase by Charles Schwab of its shares from TD Bank, TD Bank sold its entire 10.1% economic stake in Charles Schwab for a total of $14.6 billion in gross proceeds.

  • BofA Securities and J.P. Morgan as joint bookrunning managers and William Blair, TD Cowen, and Canaccord Genuity as co-managers in connection with the upsized initial public offering of 10.61 million shares of common stock of CeriBell Inc. at a public offering price of $17 per share, resulting in gross proceeds to the company of $207 million.

  • Deutsche Bank AG, as the PIPE placement agent to Lotus Technology Inc. (Lotus Tech), and Santander US Capital Markets LLC, as the capital markets advisor to L Catterton Asia Acquisition Corp. (LCAA), in connection with the business combination between Lotus Tech and LCAA. The business combination valued Lotus Tech at $5.5 billion on a pre-money equity value basis.

  • Morgan Stanley as the sole bookrunning manager in connection with the follow-on public offering of 3.99 million shares of common stock of Tidewater Inc. at a public offering price of $30.25 per share, resulting in gross proceeds to the company of approximately $120.6 million.

  • Goldman Sachs & Co. LLC as the sole bookrunning manager in connection with the follow-on public offering of 1.15 million shares of common stock of Inspire Medical Systems Inc. at a public offering price of $215 per share, resulting in gross proceeds to the company of approximately $247.2 million.

  • Morgan Stanley, Goldman Sachs & Co. LLC, Piper Sandler, and Cowen as underwriters in connection with Cytek Biosciences Inc.’s initial public offering of 16.75 million shares of common stock at a public offering price of $17 per share, resulting in gross proceeds to the company of approximately $237 million.

  • BofA Securities and Citigroup Global Markets Inc. as co-placement agents on a $2.5 billion PIPE transaction in connection with the de-SPAC combination between SPAC Churchill Capital Corp. IV and Lucid Motors Inc., an electric car manufacturer.

  • BofA Securities as sole bookrunning manager in connection with Exact Sciences’ public offering of $1.15 billion aggregate principal amount of its 0.375% convertible senior notes due 2028, including $150 million in aggregate principal amount of notes purchased by the underwriters pursuant to their fully exercised overallotment option.

See More

High-Yield Debt Offerings

  • Valvoline Inc. on the refinancing of existing debt in connection with the sale of its Global Products business to Aramco for $2.65 billion.

See More

Publications

Mujalovic, I. (2024) “Initial Public Offerings, 2024”, Global Legal Insights. The book provides CEOs, CFOs, investment bankers, general counsel, lawyers and the investing community with a detailed overview of the crucial steps, legal issues and market practices involved in an IPO process. Leading practitioners from each jurisdiction provide their expertise and guidance on navigating the US and local market practices and regulatory framework.

Mujalovic, I. (2022) “Health Care Mergers and Acquisitions Answer Book”, Practising Law Institute